Live Quote · OTCIPSEYHealthcare · Drug Manufacturers - Specialty & Generic

Ipsen S.A.

$46.51▲ 0.00%(+$0.00)

TickerSpark Score

74/100

▌ Solid

77

Valuation

80

Profitability

55

Growth

96

Health

60

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPSEY research report →

52-Week Range78% of range

Low

$30.05

Current

$46.51

High

$51.10

Company Overviewwww.ipsen.com

About the company

Ipsen S. A. , a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

CEO: David Loew
IPO: 2012
Employees: 5,502
HQ: Boulogne-Billancourt, FR

Price Chart

+54.98% · this period

Valuation

Market Cap: $61.50B
P/E: 31.79
P/S: 3.84
P/B: 3.24
EV/EBITDA: 12.20
Div Yield: 0.94%

Profitability

Gross Margin: 70.58%
Op Margin: 30.70%
Net Margin: 12.07%
ROE: 10.36%
ROIC: 15.68%

Growth & Income

Revenue: $3.53B · -1.22%
Net Income: $426.96M · 23.43%
EPS: $1.28 · 22.25%
Op Income: $716.85M
FCF YoY: 646.11%

Performance & Tape

52W High: $51.10
52W Low: $30.05
50D MA: $47.28
200D MA: $41.30
Beta: 0.32
Avg Volume: 650

Get TickerSpark's AI analysis on IPSEY

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · IPSEY